Literature DB >> 9770355

Activation of cAMP-dependent protein kinase is required for optimal alpha-melanocyte-stimulating hormone-induced pigmentation.

Y Ao1, H Y Park, S Olaizola-Horn, B A Gilchrest.   

Abstract

The cAMP-dependent pathway has been long presumed to play a critical role in mediating alpha-melanocyte-stimulating hormone (alpha-MSH)-induced pigmentation, but it has never been demonstrated that this pathway is obligatory. In order to determine whether the cAMP-dependent pathway is required for a alpha-MSH-induced pigmentation, we inhibited the activity of cAMP-dependent protein kinase (PKA), the main kinase mediating in this pathway, by introducing a physiologic cAMP-dependent protein kinase inhibitor (PKI) into S91 murine melanoma cells and then measuring pigment response after alpha-MSH stimulation. Cells were stably transfected either with the pMXX-PKI expression vector that encodes the active part of PKI (the amino terminal 1-31 amino acids) under a metallothionein-inducible promoter and the pSV2-Neo expression vector alone. As expected, treatment of transfected cells with 1 microM CdCl2 for 24 h induced the expression of PKI mRNA in cells transfected with both vectors, but not in cells transfected with the pSV2-Neo expression vector alone. Subsequent treatment of these transfected cells with alpha-MSH for 5-6 days in the continual presence of 1 microM CdCl2 resulted in inhibition of PKA activity by 30-40% in cells expressing PKI. Parallel measurements revealed that alpha-MSH-increased melanin content five- to six-fold in control cells transfected with pSV2-Neo alone, while there was only a two-fold increase in PKI-expressing cells, a 40-50% inhibition in alpha-MSH-induced total melanin content. alpha-MSH-induced tyrosinase activity and tyrosinase mRNA and protein levels measured in parallel were also inhibited by 40-50% in PKI-expressing cells compared to control cells transfected with pSV2-Neo alone. Together, these results demonstrate for the first time that activation of PKA through the cAMP-dependent pathway is required for optimal alpha-MSH-induced pigmentation. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9770355     DOI: 10.1006/excr.1998.4086

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  6 in total

1.  Human keratinocytes express functional alpha-MSH (MC1-R) receptors.

Authors:  J L Curry; W Pinto; B J Nickoloff; A T Slominski
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001-04       Impact factor: 2.416

2.  p21-activated kinase 4 critically regulates melanogenesis via activation of the CREB/MITF and β-catenin/MITF pathways.

Authors:  Cheong-Yong Yun; Soon-Tae You; Jin-Hwa Kim; Jin H Chung; Sang-Bae Han; Eun-Young Shin; Eung-Gook Kim
Journal:  J Invest Dermatol       Date:  2015-01-05       Impact factor: 8.551

3.  Inhibition of melanogenesis by the antidiabetic metformin.

Authors:  Abdelali Lehraiki; Patricia Abbe; Michael Cerezo; Florian Rouaud; Claire Regazzetti; Bérengère Chignon-Sicard; Thierry Passeron; Corine Bertolotto; Robert Ballotti; Stéphane Rocchi
Journal:  J Invest Dermatol       Date:  2014-04-22       Impact factor: 8.551

4.  Metformin: a potential drug to treat hyperpigmentation disorders.

Authors:  Elisabeth S Belisle; Hee-Young Park
Journal:  J Invest Dermatol       Date:  2014-10       Impact factor: 8.551

5.  The melanocortin receptor agonist NDP-MSH impairs the allostimulatory function of dendritic cells.

Authors:  La'Verne P Rennalls; Thomas Seidl; James M G Larkin; Claudia Wellbrock; Martin E Gore; Tim Eisen; Ludovica Bruno
Journal:  Immunology       Date:  2010-01-13       Impact factor: 7.397

6.  Tissue distribution and differential expression of melanocortin 1 receptor, a malignant melanoma marker.

Authors:  F Salazar-Onfray; M López; A Lundqvist; A Aguirre; A Escobar; A Serrano; C Korenblit; M Petersson; V Chhajlani; O Larsson; R Kiessling
Journal:  Br J Cancer       Date:  2002-08-12       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.